Enjamb Labs is a startup based in the United States, 1 tracked investor.
Based in the United States, Enjamb Labs is a startup. Brouky records 1 investor associated with the company.
Enjamb Labs provides an AI-driven platform that automates and orchestrates the full drug development process, including clinical evidence synthesis, trial design, statistical programming, and regulatory submissions, all within an auditable workspace integrated with existing pharma systems.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.